Journal of the European Academy of Dermatology and Venereology

Papers
(The H4-Index of Journal of the European Academy of Dermatology and Venereology is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Issue Information303
Announcement200
Editor's Picks January 2024192
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort164
Announcement164
152
Pioneers in Dermatology and Venereology: an interview with Professor Sarolta Kárpáti130
Peer review, scientific publishing and the law of reciprocity103
Pioneers in Dermatology and Venereology: an Interview with Professor David M. Pariser93
Pioneers in Dermatology and Venereology: An Interview with Professor An Goossens87
Clinical evaluation of anaesthetic‐like effect of two dermocosmetic formulations containing Aquaphilus dolomiae extract‐G3 in subjects with sensitive facial skin85
Pioneers in Dermatology and Venereology: An Interview with Professor Danilo V. Stevanovic80
Announcement76
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 202472
2013–2023: A decade of progress and challenges in dermatology as reflected in JEADV72
Assessing the efficacy of selective JAK inhibitors for alopecia areata with a patient‐centered approach70
Efficacy of imiquimod in the management of lentigo maligna69
High prevalence of extracutaneous involvement in ITG junctional epidermolysis bullosa67
Barrier function‐related genes and proteins have an altered expression in acne‐involved skin61
Two cases of cerebrovascular accidents following the induction dose of risankizumab59
Pityriasis lichenoides et varioliformis acuta after SARS‐CoV‐2 infection and relapse after vaccination57
Disproportionate quality of life decline and unaddressed limitations in amlitelimab atopic dermatitis trial55
Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis52
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma52
Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort52
Risk analysis of systemic side effects of tumescent local anaesthesia in the surgical treatment of geriatric and multimorbid patients with skin cancer49
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study49
Hidradenitis suppurativa: One step forward in timely diagnosis and appropriate treatment45
Are non‐fungible tokens the barrier to realizing the Dermoverse?45
Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations45
Unmet clinical needs and burden of disease in hidradenitis suppurativa: real‐world experience from EU5 and US45
Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice44
Two cases of anti‐TIF1‐γ antibody positive dermatomyositis with manifested symptoms after SARS‐CoV‐19 vaccination44
Response to ‘Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study’43
Advances in biologic therapy of psoriasis43
Identification of children at risk for the development of severe paediatric plaque psoriasis: Findings from the prospective observational long‐term Child‐CAPTURE registry43
Detecting T‐cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab43
Real‐world efficacy and safety of dupilumab in Chinese patients with atopic dermatitis: a single‐centre, prospective, open‐label study43
Urinary incontinence and female genital lichen sclerosus42
Global study reveals almost half of patients with skin disease suffer from sleep disturbances and identifies predictive factors41
Melanoma in women of childbearing age and in pregnancy in California, 1994–2015: a population‐based cohort study41
Paradoxical joint and muscle pain in a patient treated with anifrolumab and belimumab41
Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort study41
A dermocosmetic product containing the sap of oat plantlets and Garcinia mangostana extract improves the clinical signs of acne41
0.21409797668457